loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Dapsone

    Menu

    Dapsone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 667Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 86841 / DOSAGE - TABLET;ORAL - 25MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    DAPSONE(UNII: 8W5C518302)
    (DAPSONE - UNII:8W5C518302)     		DAPSONE100mg

    Inactive Ingredients

    Ingredient Name
    AvKARE, Inc.
    REMEDYREPACK INC.
    Alvogen Inc.
    Major Pharmaceuticals
    Virtus Pharmaceuticals
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)   
    croscarmellose sodium(M28OL1HH48)    
    HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)    
    magnesium stearate(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)  
    silicon dioxide(ETJ7Z6XBU4)
    STARCH, CORN(O8232NY3SJ)